Skip to content

Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer

Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03006289
Enrollment
3000
Registered
2016-12-30
Start date
2016-12-31
Completion date
2017-11-30
Last updated
2016-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer

Keywords

Metabolic Syndrome, fasting plasma glucose

Brief summary

The purpose of this study is to investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid cancer. Screen for the risk factors that affect the incidence of thyroid cancer.

Interventions

None listed

Sponsors

Lin Liao
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
8 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. patients undergone thyroid surgery 2. signed the informed consent

Exclusion criteria

1.patients with no surgery

Design outcomes

Primary

MeasureTime frame
lipidsbefore the thyroid surgery

Secondary

MeasureTime frame
glucosebefore the thyroid surgery

Other

MeasureTime frame
blood pressurebefore the thyroid surgery
Uric Acidbefore the thyroid surgery
sialic acidbefore the thyroid surgery
thyroid functionbefore the thyroid surgery

Contacts

Primary ContactLin Liao, MD
liaolin@medmail.com.cn8615168888260

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026